Se statistikken

0 antall prosjekter

Dato fra ny til gammel

EIC-The European Innovation Council (EIC)

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

NEXT GENERATION IMAGING FOR REAL-TIME DOSE VERIFICATION ENABLING ADAPTIVE PROTON THERAPY

Tildelt: kr 17,8 mill.

Prosjektperiode: 2024-2028

Sted: Vestland

EIC-The European Innovation Council (EIC)

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.

Tildelt: kr 25,2 mill.

Prosjektperiode: 2024-2028

Sted: Oslo

CL1-Health

Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

Tildelt: kr 44,6 mill.

Prosjektperiode: 2024-2027

Sted: Oslo og 2 andre

MSCA-Marie Sklodowska-Curie Actions (MSCA)

DSTrain - Data Science Postdoctoral Training Programme

DSTrain - Data Science Postdoctoral Training Programme

Tildelt: kr 52,1 mill.

Prosjektperiode: 2024-2028

Sted: Akershus og 12 andre

CL1-Health

ENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION

ENTEROVIRUS-LINKED TYPE 1 DIABETES EXPOSED -MECHANISMS AND PREVENTION

Tildelt: kr 7,3 mill.

Prosjektperiode: 2024-2027

Sted: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Human - Centric Indoor Climate for Healthcare Facilities

Human - Centric Indoor Climate for Healthcare Facilities

Tildelt: kr 9,0 mill.

Prosjektperiode: 2024-2027

Sted: Trøndelag - Trööndelage

CL1-Health

The first European Digital Health Technology Assessment framework co-created by all stakeholders along the value chain

The first European Digital Health Technology Assessment framework co-created by all stakeholders along the value chain

Tildelt: kr 21,5 mill.

Prosjektperiode: 2024-2027

Sted: Troms - Romsa - Tromssa og 2 andre

CL1-Health

The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics

The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics

Tildelt: kr 12,2 mill.

Prosjektperiode: 2024-2028

Sted: Oslo

CL1-Health

Development of a global diagnostic ecosystem for detecting and monitoring emergency-prone pathogens across species and in a unified way

Development of a global diagnostic ecosystem for detecting and monitoring emergency-prone pathogens across species and in a unified way

Tildelt: kr 9,4 mill.

Prosjektperiode: 2023-2027

Sted: Vestland

CL1-Health

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Targeting Epstein-Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis

Tildelt: kr 29,6 mill.

Prosjektperiode: 2023-2028

Sted: Akershus og 5 andre

CL5-Climate, Energy and Mobility

From solar energy to fuel: A holistic artificial photosynthesis platform for the production of viable solar fuels

From solar energy to fuel: A holistic artificial photosynthesis platform for the production of viable solar fuels

Tildelt: kr 21,8 mill.

Prosjektperiode: 2023-2027

Sted: Oslo og 2 andre

CL1-Health

PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM

PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM

Tildelt: kr 11,9 mill.

Prosjektperiode: 2023-2027

Sted: Rogaland

ERC-European Research Council (ERC)

Targeting Acute Leukemia with TdT-TCR-T-cell therapy

Targeting Acute Leukemia with TdT-TCR-T-cell therapy

Tildelt: kr 1,7 mill.

Prosjektperiode: 2023-2025

Sted: Oslo og 2 andre

CL1-Health

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

Tildelt: kr 18,2 mill.

Prosjektperiode: 2023-2028

Sted: Oslo

CL1-Health

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

Tildelt: kr 0,10 mill.

Prosjektperiode: 2023-2027

Sted: Oslo

CL1-Health

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND

Tildelt: kr 1,8 mill.

Prosjektperiode: 2023-2027

Sted: Vestland

CL1-Health

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

Tildelt: kr 3,2 mill.

Prosjektperiode: 2023-2026

Sted: Oslo

CL1-Health

IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs

IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs

Tildelt: kr 3,7 mill.

Prosjektperiode: 2023-2028

Sted: Akershus

CL1-Health

International Study for Treatment of Childhood Relapsed ALL 2020

International Study for Treatment of Childhood Relapsed ALL 2020

Tildelt: kr 1,1 mill.

Prosjektperiode: 2023-2028

Sted: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.

Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.

Tildelt: kr 2,9 mill.

Prosjektperiode: 2023-2026

Sted: Oslo

CL1-Health

Establishing of Cancer Mission Hubs: Networks and Synergies

Establishing of Cancer Mission Hubs: Networks and Synergies

Tildelt: kr 3,7 mill.

Prosjektperiode: 2023-2026

Sted: Oslo og 3 andre

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles

Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles

Tildelt: kr 3,0 mill.

Prosjektperiode: 2023-2027

Sted: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Determining Genetic Bases of Differential Response to Antipsychotics Using Patient-Derived Neurons

Determining Genetic Bases of Differential Response to Antipsychotics Using Patient-Derived Neurons

Tildelt: kr 3,1 mill.

Prosjektperiode: 2023-2025

Sted: Vestland

WIDENING-Widening participation and spreading excellence

Diabetes, obesity and the Kidney

Diabetes, obesity and the Kidney

Tildelt: kr 2,9 mill.

Prosjektperiode: 2023-2025

Sted: Oslo

ERC-European Research Council (ERC)

Final act of the autophagy symphony: Whole-organism orchestration of autophagy termination

Final act of the autophagy symphony: Whole-organism orchestration of autophagy termination

Tildelt: kr 15,2 mill.

Prosjektperiode: 2023-2027

Sted: Oslo

CL1-Health

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Tildelt: kr 3,5 mill.

Prosjektperiode: 2023-2025

Sted: Vestland

CL1-Health

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

Tildelt: kr 7,6 mill.

Prosjektperiode: 2023-2026

Sted: Oslo

CL1-Health

Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

Tildelt: kr 21,1 mill.

Prosjektperiode: 2022-2027

Sted: Oslo

EIC-The European Innovation Council (EIC)

Supervised morphogenesis in gastruloids

Supervised morphogenesis in gastruloids

Tildelt: kr 13,6 mill.

Prosjektperiode: 2022-2027

Sted: Oslo

CL1-Health

Fostering a European Research Area for Health Research

Fostering a European Research Area for Health Research

Tildelt: kr 15,8 mill.

Prosjektperiode: 2022-2029

Sted: Vestland og 2 andre

1 2 3 4 5